Assessment of the American Joint Committee on Cancer staging (sixth and seventh editions) for clinically localized prostate cancer treated with external beam radiotherapy and comparison with the National Comprehensive Cancer Network risk-stratification method.

Abstract Text

The objective of this study was to compare the prognostic value of the sixth and seventh editions of the American Joint Cancer Committee (AJCC) Cancer Staging Manual and the risk-stratification model of the National Comprehensive Cancer Network (NCCN).

Authors :-, , , , ,


Keywords :-, , , ,


Mesh Headings :-


Chemical List :-,



2016-09-08 05:53:28

Click download button below to get the free Assessment of the American Joint Committee on Cancer staging (sixth and seventh editions) for clinically localized prostate cancer treated with external beam radiotherapy and comparison with the National Comprehensive Cancer Network risk-stratification method. link to pdf of abstract on your facebook profile.

Download Server - Asia Download Server - America Download Server - Europe Download Server - Australia
Citation:- Zaorsky NG, Li NG, Devarajan NG, Horwitz NG, Buyyounouski NG, .Assessment of the American Joint Committee on Cancer staging (sixth and seventh editions) for clinically localized prostate cancer treated with external beam radiotherapy and comparison with the National Comprehensive Cancer Network risk-stratification method. Cancer 2012-Nov;118()5535-43 DOI:10.1002/cncr.27597

Link to original article


Details of Journal

Journal Title - Cancer

ISSN - 1097-0142

Volume - 118

Issue - 22

Publish date - 2012-Nov

Language - eng

Country - United States


SHARE PLEASE -
Read More Similar Articles

Definitive radiotherapy for stage I nonsmall cell lung cancer: a population-based study of survival.

Milano MT, Zhang MT, Usuki MT, Singh MT, Chen MT, .Definitive radiotherapy for stage I nonsmall cell lung cancer: a population-based study of survival. Cancer 2012-Nov;118()5572-9 DOI:10.1002/cncr.275.......

Read More

The long-term outcome of treated high-risk nonmuscle-invasive bladder cancer: time to change treatment paradigm?

Thomas F, Rosario F, Rubin F, Goepel F, Abbod F, Catto F, .The long-term outcome of treated high-risk nonmuscle-invasive bladder cancer: time to change treatment paradigm? Cancer 2012-Nov;118()5525-34.......

Read More

Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Comprehensive Cancer Network.

Lin NU, Vanderplas NU, Hughes NU, Theriault NU, Edge NU, Wong NU, .Clinicopathologic features, patterns of recurrence, and survival among women with triple-negative breast cancer in the National Compr.......

Read More

Impact of diagnosis and treatment of clinically localized prostate cancer on health-related quality of life for older Americans: a population-based study.

Reeve BB, Stover BB, Jensen BB, Chen BB, Taylor BB, Clauser BB, .Impact of diagnosis and treatment of clinically localized prostate cancer on health-related quality of life for older Americans: a popu.......

Read More

Phase 2 trial of maintenance bevacizumab alone after bevacizumab plus pemetrexed and carboplatin in advanced, nonsquamous nonsmall cell lung cancer.

Stevenson JP, Langer JP, Somer JP, Evans JP, Rajagopalan JP, Krieger JP, .Phase 2 trial of maintenance bevacizumab alone after bevacizumab plus pemetrexed and carboplatin in advanced, nonsquamous nons.......

Read More

Clinical significance of SOD2 and GSTP1 gene polymorphisms in Chinese patients with gastric cancer.

Xu Z, Zhu Z, Luk Z, Wu Z, Gu Z, Gong Z, .Clinical significance of SOD2 and GSTP1 gene polymorphisms in Chinese patients with gastric cancer. Cancer 2012-Nov;118()5489-96 DOI:10.1002/cncr.27599.......

Read More

Thyroid cancer incidence by histological type and related variants in a mildly iodine-deficient area of Northern Italy, 1998 to 2009.

Ceresini G, Corcione G, Michiara G, Sgargi G, Teresi G, Gilli G, .Thyroid cancer incidence by histological type and related variants in a mildly iodine-deficient area of Northern Italy, 1998 to 2009. .......

Read More

Proteasome inhibitor interacts synergistically with autophagy inhibitor to suppress proliferation and induce apoptosis in hepatocellular carcinoma.

Hui B, Shi B, Ding B, Zhou B, Gu B, Peng B, .Proteasome inhibitor interacts synergistically with autophagy inhibitor to suppress proliferation and induce apoptosis in hepatocellular carcinoma. Cancer .......

Read More

A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306).

Nabors LB, Mikkelsen LB, Hegi LB, Ye LB, Batchelor LB, Lesser LB, .A safety run-in and randomized phase 2 study of cilengitide combined with chemoradiation for newly diagnosed glioblastoma (NABTT 0306.......

Read More